✦ LIBER ✦

Tolvaptan in Autosomal Dominant Polycystic Kidney Disease

Book ID: 127252500
Publisher: Massachusetts Medical Society
Year: 2013
Tongue: English
Weight: 327 KB
Volume: 368
Category: Article
ISSN: 0096-6762
DOI: 10.1056/nejmc1300762

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tolvaptan in Patients with Autosomal Dom

Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease

✍ Torres, Vicente E.; Chapman, Arlene B.; Devuyst, Olivier; Gansevoort, Ron T.; Gr 📂 Article 📅 2012 🏛 Massachusetts Medical Society 🌐 English ⚖ 897 KB

Commentary on: Tolvaptan in Patients Wit

Commentary on: Tolvaptan in Patients With Autosomal-Dominant Polycystic Kidney Disease

✍ Black, Peter; Sutton, Roger 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Short-term effects of tolvaptan on renal

Short-term effects of tolvaptan on renal function and volume in patients with autosomal dominant polycystic kidney disease

✍ Irazabal, Maria V; Torres, Vicente E; Hogan, Marie C; Glockner, James; King, Ber 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 216 KB

Isn’t It Ironic? Cost-Effectiveness and

Isn’t It Ironic? Cost-Effectiveness and Willingness to Pay for Tolvaptan in the Prevention of Kidney Failure in Autosomal Dominant Polycystic Kidney Disease

✍ Nee, Robert; Yuan, Christina M.; Abbott, Kevin C. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 111 KB

Rationale and Design of the TEMPO (Tolva

Rationale and Design of the TEMPO (Tolvaptan Efficacy and Safety in Management of Autosomal Dominant Polycystic Kidney Disease and Its Outcomes) 3-4 Study

✍ Vicente E. Torres; Esther Meijer; Kyongtae T. Bae; Arlene B. Chapman; Olivier De 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 418 KB

Review of Tolvaptan for Autosomal Domina

Review of Tolvaptan for Autosomal Dominant Polycystic Kidney Disease

✍ Baur, Brian P.; Meaney, Calvin J. 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB